Retrospective Study Evaluating ABRYSVO® Vaccine Effectiveness Against Severe Lower Respiratory Tract Disease in Older Adults

Study identification

• EU PAS number:
  EUPAS1000000460
• Study ID:
  1000000460
• Official title and acronym:
  Retrospective Study Evaluating ABRYSVO® Vaccine Effectiveness Against Severe Lower Respiratory Tract Disease in Older Adults
• DARWIN EU® study:
  No
• Study countries:
  United States
• Study status:
  Ongoing

Study timelines

Date when funding contract was signed

Planned: 11/09/2023

Actual: 11/09/2023

Study start date

Planned: 01/11/2023

Actual: 01/11/2023

Date of final study report

Planned: 01/09/2029

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable

Other study registration identification numbers and links

C3671030